Glenmark Pharmaceuticals (GLENMARK.NSE) Q4 2025 Earnings

Nov 14Confirmed
Q1 2025
Q2 2025
Q3 2025
Q4 2025
1.69
8.32
14.95
21.57

Details

Expected EPS
N/A
Actual EPS
21.5742438644
Surprise EPS
N/A
Surprise Percent
N/A

Description

⁨Glenmark Pharmaceuticals⁩ (⁦GLENMARK.NSE⁩) has reported earnings of ⁦21.5742438644⁩ per share for ⁦Q4 2025⁩.

0 Comments

Share your thoughts